Galderma

Switzerland
Malters, Lucerne, Switzerland, 1018

Company profile

Galderma company profile

Galderma is a global company founded in 1981 committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 33 wholly-owned affiliates with a worldwide network of distributors and approximately 5,500 employees. Galderma’s extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence. Strategic brands include Epiduo®, Oracea®, Clobex®, Differin®, Mirvaso®, Rozex®/MetroGel®, Silkis®/Vectical®, Tri-Luma®, Loceryl®, Cetaphil®, Metvix®, Azzalure®, Restylane® and Emervel®.

Business identity

Phone number
41 21 642 78 00
Operating status
Active
Company type
For Profit
Revenue range
$100M-$1B
Founded
1981-01-01, Year

Headquarters

Postal code
1018
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
6
Last funding
Post IPO Secondary / $4.8B / 2025-12-08
Investors
3
Lead investors
3
Founders
1
Articles
602
Exited on
2024-03-22

Categories and groups

Founders and investors

Founders

M Owen

Lead investors

BNP ParibasL'OrealUBS

Investors

BNP ParibasL'OrealUBS